Say goodbye to dieting frustration, embrace a healthier, more confident you
The Medicare GLP-1 Bridge Program was developed to evaluate whether expanding access to certain FDA-approved weight-loss medications can improve patient outcomes while potentially reducing long-term healthcare costs
Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats
Best for: Strong hormetic stress
The area under the concentration curve obtained when administered at the same dose, corresponds approximately to twice that obtained when it is applied by oral or rectal route, as the active principle is metabolized almost 50% during its first passage through the liver (first pass effect), when administered by the routes mentioned
Notably, clinician consensus on obesity as a chronic disease remains limited, with less than half routinely documenting it as such